COVID-19 Prevention and Treatment
Here you’ll find the most comprehensive and current information when it comes to the prevention and treatment of COVID-19.
COVID-19 prevention and treatments are constantly improving. Check here for the latest advances in prevention and disease management. Read about breaking research and news concerning vaccines, monoclonal antibodies, and other therapeutics with a focus on the immune compromised.
ADDITIONAL READING
The COVID-19 mortality rate was lower in recently vaccinated cancer patients and the same was true for B-cell cancers, including those with CLL.
Nirmatrelvir-ritonavir (Paxlovid) reduced the risk of death among immunocompromised patients who were hospitalized with COVID-19.
CLL Society has created our Statement on Mask Wearing and Other Protective Measures for Those Living with CLL to protect against respiratory infections spread.
Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.
Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.
Now there is a new trial (SUPERNOVA) of an updated mix of monoclonal antibodies that hopes to provide durable protection against present and future variants of concerns.
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
